Hathaway Helen J, Evans Susan C, Dubois Daniel H, Foote Cynthia I, Elder Brooke H, Shur Barry D
Department of Cell Biology, Emory University School of Medicine, Atlanta, GA, USA.
J Cell Sci. 2003 Nov 1;116(Pt 21):4319-30. doi: 10.1242/jcs.00720. Epub 2003 Sep 9.
Beta1,4-galactosyltransferase I (GalT I) exists in two subcellular compartments where it performs two distinct functions. The majority of GalT I is localized in the Golgi complex where it participates in glycoprotein biosynthesis; however, a small portion of GalT I is expressed on the cell surface where it functions as a matrix receptor by binding terminal N-acetylglucosamine residues on extracellular glycoside ligands. The GalT I polypeptide occurs in two alternate forms that differ only in the length of their cytoplasmic domains. It is thought that the longer cytoplasmic domain is responsible for GalT I function as a cell surface receptor because of its ability to associate with the detergent-insoluble cytoskeleton. In this study, we demonstrate that the long GalT I cytoplasmic and transmembrane domains are capable of targeting a reporter protein to the plasma membrane, whereas the short cytoplasmic and transmembrane domains do not have this property. The surface-localized GalT I reporter protein partitions with the detergent-insoluble pool, a portion of which co-fractionates with caveolin-containing lipid rafts. Site-directed mutagenesis of the cytoplasmic domain identified a requirement for serine and threonine residues for cell surface expression and function. Replacing either the serine or threonine with aspartic acid reduces surface expression and function, whereas substitution with neutral alanine has no effect on surface expression or function. These results suggest that phosphorylation negatively regulates GalT I function as a surface receptor. Consistent with this, phosphorylation of the endogenous, full-length GalT I inhibits its stable expression on the cell surface. Thus, the 13 amino acid extension unique to the long GalT I isoform is required for GalT I expression on the cell surface, the function of which is regulated by phosphorylation.
β1,4-半乳糖基转移酶I(GalT I)存在于两个亚细胞区室中,在那里它执行两种不同的功能。大多数GalT I定位于高尔基体复合体中,在那里它参与糖蛋白的生物合成;然而,一小部分GalT I在细胞表面表达,在那里它通过结合细胞外糖苷配体上的末端N-乙酰葡糖胺残基而作为基质受体发挥作用。GalT I多肽以两种交替形式出现,它们仅在细胞质结构域的长度上有所不同。据认为,较长的细胞质结构域负责GalT I作为细胞表面受体的功能,因为它能够与去污剂不溶性细胞骨架结合。在本研究中,我们证明长GalT I细胞质和跨膜结构域能够将报告蛋白靶向质膜,而短细胞质和跨膜结构域则没有这种特性。表面定位的GalT I报告蛋白与去污剂不溶性部分一起分配,其中一部分与含小窝蛋白的脂筏共分离。细胞质结构域的定点诱变确定了细胞表面表达和功能对丝氨酸和苏氨酸残基的需求。用天冬氨酸取代丝氨酸或苏氨酸会降低表面表达和功能,而用中性丙氨酸取代则对表面表达或功能没有影响。这些结果表明磷酸化负向调节GalT I作为表面受体的功能。与此一致的是,内源性全长GalT I的磷酸化抑制其在细胞表面的稳定表达。因此,长GalT I同工型特有的13个氨基酸延伸对于GalT I在细胞表面的表达是必需的,其功能受磷酸化调节。